Leslie Lazarus

Last updated

Leslie Lazarus (left) and professor John Shine looking at a model of the Garvan Institute building (back right) and then-proposed adjoining facilities. Dr Les Lazarus and Professor Shine Garvan at the Garvan Institute.jpg
Leslie Lazarus (left) and professor John Shine looking at a model of the Garvan Institute building (back right) and then-proposed adjoining facilities.

Leslie "Les" Lazarus AO (11 December 1929 - 17 December 2022) was an Australian endocrinologist who was one of the first co-Directors of the Garvan Institute of Medical Research, Sydney from 1966 to 1969 and sole Director from 1969 to 1990. At the Garvan Institute he led a joint laboratory and clinical research team studying diabetes and pituitary hormone secretions, in particular the secretion and clinical uses of human growth hormone. [1]

Contents

From 1974 until 1988 Lazarus was an Associate Professor of medicine at the University of New South Wales and from 1988 until 1995 he was a Professor of medicine at the University of New South Wales. In 1995 he was appointed an Emeritus Consultant to St Vincent's Hospital, Sydney.

Early years and education

Leslie Lazarus was born in Sydney and educated at Sydney Boys High School and the University of Sydney, which he entered on a scholarship (Public Exhibitioner) in 1947. He graduated in Medicine in 1953 and after clinical training at St Vincent's Hospital, Sydney was admitted to the Royal Australasian College of Physicians (MRACP) in 1958 and as a Fellow in 1968. In 1969, he was admitted as a Fellow of the Australasian Association of Clinical Biochemists (FAACB) and in 1977, he was admitted as a Fellow of the Royal College of Pathologists of Australasia (FRCPA).

In 1959–61, Lazarus was a Research Fellow at the Institute for Clinical Research at the Middlesex Hospital Medical School, London where he was mentored by the Endocrinologist, Sir John Nabarro. [1] In 1962, Lazarus was appointed Staff Clinical Endocrinologist to St Vincent's Hospital, Sydney and established its first endocrine laboratory. [2] In 1963, the endocrine laboratory was transferred to the newly opened Garvan Institute of Medical Research. [2] In 1967, he was appointed consultant endocrinologist to the Royal Alexandra Hospital for Children, Sydney.

Career

In 1958, Lazarus was one of the founders of the Endocrine Society of Australia and in 1982, he was made a Life Member of the Endocrine Society of Australia. [3] In 1988, he was appointed an Officer in the Order of Australia (AO) "For service to medicine, particularly in the field of medical research". [1] In 1993, he was the Roman Travelling Lecturer of the Australasian Association of Clinical Biochemists. In this role he visited all of the Australian and New Zealand capital cities to give the Roman Lecture for 1993, on "The Clinical Biochemist as Information Scientist".

In 1990, Lazarus retired from the position of Executive Director of the Garvan Institute to become Director of the Department of Biochemistry at St Vincent's Hospital and then in 1991, the Executive Director of the Institute of Laboratory Medicine. In 1998, he was one of the founders, together with Paul Justin Compton, of Pacific Knowledge Systems [4] an information technology company utilising Paul Compton's concept of Ripple Down Rules to provide automated interpretative reports for pathology laboratories worldwide.

Development of the Garvan Institute

Under the direction of Leslie Lazarus the research activity of the Garvan Institute grew from a small endocrine laboratory of St Vincent’s Hospital in 1963 to a major institute of national importance that was incorporated by an Act of the New South Wales Government in 1984[1] . In 1982, the National Health and Medical Research Council (NHMRC) awarded the Garvan Institute its first Program Grant for research into diabetes. In 1986, the Garvan Institute became one of only five ‘centres of research excellence’ in Australia to receive NHMRC ‘block funding’.

Achievements

During the first decades of the Garvan the key achievements were: the use of a cryogenic probe for the treatment of pituitary tumours, [5] the use of insulin infusions for the treatment of severe diabetes, [6] demonstration of the role of growth hormone in foetal brain growth, [7] a study of the growth and fitness of Australian children, [8] the development of an artificial pancreas for the treatment of diabetes, [9] the role of growth hormone in breast cancer, [10] the production and use of biosynthetic human growth hormone [11] and the development of a computer expert system for the interpretation of laboratory results. [12]

Related Research Articles

<span class="mw-page-title-main">Endocrinology</span> Branch of medicine dealing the endocrine system

Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. It is also concerned with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, sleep, digestion, respiration, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones. Specializations include behavioral endocrinology and comparative endocrinology.

Thyroid-stimulating hormone (also known as thyrotropin, thyrotropic hormone, or abbreviated TSH) is a pituitary hormone that stimulates the thyroid gland to produce thyroxine (T4), and then triiodothyronine (T3) which stimulates the metabolism of almost every tissue in the body. It is a glycoprotein hormone produced by thyrotrope cells in the anterior pituitary gland, which regulates the endocrine function of the thyroid.

Pediatric endocrinology is a medical subspecialty dealing with disorders of the endocrine glands, such as variations of physical growth and sexual development in childhood, diabetes and many more.

<span class="mw-page-title-main">Zvi Laron</span>

Zvi Laron is an Israeli paediatric endocrinologist. Born in Cernăuţi, Romania, Laron is a professor emeritus at Tel Aviv University. In 1966, he described the type of dwarfism later called Laron syndrome. His research opened the way to the treatment of many cases of growth hormone disorders. He was the first to introduce the multidisciplinary treatment for juvenile diabetes.

The Kolling Institute is located in the grounds of the Royal North Shore Hospital in St Leonards, Sydney Australia. The institute, founded in 1920, is the oldest medical research institute in New South Wales.

<span class="mw-page-title-main">Garvan Institute of Medical Research</span>

The Garvan Institute of Medical Research is an Australian biomedical research institute located in Darlinghurst, Sydney, New South Wales. Founded in 1963 by the Sisters of Charity as a research department of St Vincent's Hospital, it is now one of Australia's largest medical research institutions, with approximately 750 scientists, students and support staff.

<span class="mw-page-title-main">Donald F. Steiner</span> American biochemist

Donald Frederick Steiner was an American biochemist and a professor at the University of Chicago.

<span class="mw-page-title-main">Baker Heart and Diabetes Institute</span>

The Baker Heart and Diabetes Institute, commonly known as the Baker Institute, is an Australian independent medical research institute headquartered in Melbourne, Victoria. Established in 1926, the institute is one of Australia's oldest medical research organisations with a historical focus on cardiovascular disease. In 2008, it became the country's first medical research institute to target diabetes, heart disease, obesity and their complications at the basic, clinical and population health levels.

Christopher Carl Goodnow is an immunology researcher and the current executive director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney. He holds dual Australian and US citizenship.

Derek LeRoith is a South African endocrinologist and Professor of Medicine and the current Chief of the Hilda and J. Lester Gabrilove, M.D. Division of Endocrinology, Diabetes and Bone Disease and Director of the Metabolism Institute of the Mount Sinai Medical Center in New York City. He is an international expert in insulin-like growth factor-1 (IGF-1).

<span class="mw-page-title-main">Kenneth Adie Ferguson</span>

Kenneth Adie Ferguson was an Australian veterinary scientist.

<span class="mw-page-title-main">Leonid Poretsky</span>

Leonid Poretsky is a Russian-born American endocrinologist. His research interests include mechanisms of insulin action in the ovary, endocrinological aspects of AIDS, and clinical outcomes in diabetes. He has authored over 100 publications and has served on the National Institutes of Health's review committees and on the editorial boards of the Journal of Clinical Endocrinology and Metabolism and other endocrine journals.

Shashank R. Joshi is an Indian endocrinologist, diabetologist and medical researcher, considered by many as one of the prominent practitioners of the trade in India. He was honoured by the Government of India, in 2014, by bestowing on him the Padma Shri, the fourth highest civilian award, for his services to the field of medicine. He is a part of the COVID-19 Task Force for the state of Maharashtra, India.

<span class="mw-page-title-main">Daniel J. Drucker</span> Canadian endocrinologist

Daniel Joshua Drucker is a Canadian endocrinologist. A Fellow of the Royal Society, he is a professor of medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto. He is known for his research into intestinal hormones and their use in the treatment of diabetes and other metabolic diseases.

<span class="mw-page-title-main">Creswell Eastman</span>

Creswell John Eastman is the Clinical Professor of Medicine at Sydney University Medical School, Principal of the Sydney Thyroid Clinic and Consultant Emeritus to the Westmead Hospital. Eastman is an endocrinologist and has directed or conducted research and public health projects into elimination of iodine deficiency disorders (IDD) in Malaysia, Indonesia, Laos, Cambodia, Thailand, several Pacific Islands, Hong Kong, China and Tibet and Australia. For his work in remote areas of China, he has been dubbed the "man who saved a million brains".

Lesley Veronica Campbell is an Australian endocrinologist and Professor of Medicine with a special interest in clinical diabetes, appetite and metabolism. She is a principal research fellow at the Garvan Institute of Medical Research in Sydney, Australia.

Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015, and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).

Katherine Samaras is the laboratory head at the Garvan Institute of Medical Research. She holds positions at St Vincent's Clinic, and University of New South Wales, as well as the University of Notre Dame.

Louise Maple-Brown is an Australian endocrinologist. She is a clinical researcher at the Royal Darwin Hospital, serving as the hospital's Head of Endocrinology and as NHMRC Practitioner Fellow with the Menzies School of Health Research at Charles Darwin University. She leads a clinical research program within the Wellbeing and Preventable Chronic Diseases division of Menzies with a focus on diabetes in Indigenous Australians and provides clinical diabetes services to urban and remote Northern Territory communities.

Joseph Edward Rall was an American endocrinologist and research director at the National Institutes of Health. He was an expert on the thyroid gland, particularly its proteins and its relationship with radioactive iodine.

References

  1. 1 2 3 "Lazarus, Leslie". www.sydney.edu.au. University of Sydney . Retrieved 12 July 2015.
  2. 1 2 "History". St Vincent's Hospital web site. Retrieved 12 July 2015.
  3. ↑ "Honorary Life Members". www.endocrinesociety.org.au. The Endocrine Society of Australia. Retrieved 12 July 2015.
  4. ↑ Zaiane, Osmar R.; Simoff, Simeon; Djeraba, Chabane (2003). Mining Multimedia and Complex Data: KDD Workshop MDM/KDD 2002, PAKDD Workshop KDMCD 2002, Revised Papers . Springer. p.  214. ISBN   978-3-540-39666-6. Particular thanks to Les Lazarus and Michael Harries of PKS
  5. ↑ Bleasel, K; Lazarus, L (1965). "Cryogenic hypophysectomy". The Medical Journal of Australia . 2 (4): 147–149. doi:10.5694/j.1326-5377.1965.tb18691.x. PMID   14348044.
  6. ↑ Kidson, W; Casey, JH; Kraegen, EW; Lazarus, L (1974). "The treatment of severe diabetes mellitus by insulin infusion". Br Med J . 2 (5921): 691–694. doi:10.1136/bmj.2.5921.691. PMC   1611113 . PMID   4855256.
  7. ↑ Sara, V; Lazarus, L; Stuart, MC; King, T (1974). "Fetal brain growth; selective action by growth hormone". Science . 186 (4162): 446–447. doi:10.1126/science.186.4162.446. PMID   4471675. S2CID   38297604.
  8. ↑ Russo, P; Sutton, J; Lazarus, L (1975). A growth and fitness study of Sydney school children, in Studies of the Australian Adolescent. Cassell. pp. 7–36.
  9. ↑ Kraegen, EW; Campbell, L; Lazarus, L (1977). "Control of blood glucose in diabetics using an artificial pancreas". Australian and New Zealand Journal of Medicine. 7 (3): 280–286. doi:10.1111/j.1445-5994.1977.tb03687.x. PMID   334138.
  10. ↑ Murphy, LJ; Lazarus, L (1984). "Growth hormone binding to cultured breast cancer cells". The Journal of Clinical Endocrinology and Metabolism . 58 (1): 149–156. doi: 10.1210/jcem-58-1-149 . PMID   6315757.
  11. ↑ Ho, KY; Weissberger, AJ; Stuart, MC; Day, RO; Lazarus, L (1989). "The pharmacokinetics, safety and endocrine effects of authentic biosynthetic growth hormone in man". Clin Endocrinol. 30 (4): 335–345. doi:10.1111/j.1365-2265.1989.tb00431.x. PMID   2598470. S2CID   22787928.
  12. ↑ Horn, K; Compton, PJ; Lazarus, L; Quinlan, JR (1985). "Expert Systems for the Clinical Interpretation of Laboratory Reports". Clinical Chemistry. pp. 7–11. doi:10.1007/978-1-4613-0753-2_63. ISBN   978-1-4612-8065-1.{{cite book}}: |journal= ignored (help)
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.